Cardiorespiratory Aspects of Duchenne Muscular Dystrophy: New Perspectives and Controversies is designed to address key challenges in the field by providing a cardiorespiratory perspective on clinical care, drug development, and the regulatory approval of new drugs. The book discusses current achievements and limitations of care and addresses clinical challenges. It offers a detailed, critical examination of the drug development process and identifies potential flaws in current regulatory processes. Novel recommendations for improving study methodologies and regulatory decisions are discussed, with the goal of enabling more effective drugs to reach individuals with Duchenne Muscular Dystrophy (DMD). This book is designed to provide important and interesting information to a variety of stakeholders, including clinicians, researchers, and regulators, as well as patients and their caregivers. Clinicians will find a summary of standards of care and strategies to overcome the challenges they are likely to face in enacting those standards. Researchers will gain insights into the crucial importance of cardiorespiratory outcome measures and find recommendations designed to improve study methodologies. Regulators will benefit from an examination of potential flaws in the current drug approval process and from proposed recommendations aimed at ensuring that approved drugs are truly effective. The goal of this comprehensive approach is to enhance the outcomes and survival of individuals with DMD by focusing on key determinants of cardiorespiratory health.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Dr. Birnkrant is Professor Emeritus of Pediatrics at Case Western Reserve University School of Medicine and a board-certified clinician in pediatric pulmonology and sleep medicine.
With over 25 years in the pediatric neuromuscular clinic, he has dedicated his career to caring for individuals with neuromuscular diseases, particularly focusing on the cardiorespiratory management of Duchenne muscular dystrophy (DMD).
He has developed patents for respiratory devices to improve ventilatory assistance and has published extensively on DMD, emphasizing survival prolongation, anesthetic management, noninvasive ventilation, new drug therapies, and cardiorespiratory phenotypic variability.
His recent work critiques DMD drug study methodologies and regulatory pathways. Dr. Birnkrant was the lead author of the 2018 “Care Considerations for Duchenne Muscular Dystrophy” in The Lancet Neurology, now a standard of care.
He serves on the Editorial Board of Pediatric Pulmonology, has consulted for the FDA, and is the 2024 recipient of the Margaret Pfrommer Endowed Memorial Lecture award in home-based mechanical ventilation.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Paperback. Etat : new. Paperback. Cardiorespiratory Aspects of Duchenne Muscular Dystrophy: A New Approach for Clinicians, Researchers and Regulators Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9780443415982
Quantité disponible : 1 disponible(s)
Vendeur : Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlande
Etat : New. 2026. 1st Edition. paperback. . . . . . N° de réf. du vendeur V9780443415982
Quantité disponible : 10 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Advances the delivery of cardiorespiratory-focused care for individuals with DMDIdentifies potential flaws in current DMD drug study methodologies and recommends key improvementsExamines problems with the current DMD drug approval . N° de réf. du vendeur 3186215287
Quantité disponible : 4 disponible(s)
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Paperback. Etat : new. Paperback. Cardiorespiratory Aspects of Duchenne Muscular Dystrophy: A New Approach for Clinicians, Researchers and Regulators Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9780443415982
Quantité disponible : 1 disponible(s)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 200 pages. 8.50x0.47x10.87 inches. In Stock. N° de réf. du vendeur xr0443415986
Quantité disponible : 2 disponible(s)
Vendeur : UK BOOKS STORE, London, LONDO, Royaume-Uni
Etat : New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability. N° de réf. du vendeur CBS 9780443415982
Quantité disponible : 1 disponible(s)
Vendeur : Kennys Bookstore, Olney, MD, Etats-Unis
Etat : New. 2026. 1st Edition. paperback. . . . . . Books ship from the US and Ireland. N° de réf. du vendeur V9780443415982
Quantité disponible : 10 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. Neuware - Cardiorespiratory Aspects of Duchenne Muscular Dystrophy: New Perspectives and Controversies is designed to address key challenges in the field by providing a cardiorespiratory perspective on clinical care, drug development, and the regulatory approval of new drugs. The book discusses current achievements and limitations of care and addresses clinical challenges. It offers a detailed, critical examination of the drug development process and identifies potential flaws in current regulatory processes. Novel recommendations for improving study methodologies and regulatory decisions are discussed, with the goal of enabling more effective drugs to reach individuals with Duchenne Muscular Dystrophy (DMD).This book is designed to provide important and interesting information to a variety of stakeholders, including clinicians, researchers, and regulators, as well as patients and their caregivers. Clinicians will find a summary of standards of care and strategies to overcome the challenges they are likely to face in enacting those standards. Researchers will gain insights into the crucial importance of cardiorespiratory outcome measures and find recommendations designed to improve study methodologies. Regulators will benefit from an examination of potential flaws in the current drug approval process and from proposed recommendations aimed at ensuring that approved drugs are truly effective. The goal of this comprehensive approach is to enhance the outcomes and survival of individuals with DMD by focusing on key determinants of cardiorespiratory health. N° de réf. du vendeur 9780443415982
Quantité disponible : 1 disponible(s)
Vendeur : AussieBookSeller, Truganina, VIC, Australie
Paperback. Etat : new. Paperback. Cardiorespiratory Aspects of Duchenne Muscular Dystrophy: A New Approach for Clinicians, Researchers and Regulators Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. N° de réf. du vendeur 9780443415982
Quantité disponible : 1 disponible(s)